The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 2:30 - 5:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 2:30 - 5:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 2:30 - 5:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD279 (PD-1) expression on resting and activated mouse splenocytes. Splenocytes from a C57BL/6 mouse were activated in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody (Cat. No. 553057) for 3 days. The resting (Left Panel) or activated (Right Panel) splenocytes were stained with either a BD Horizon™ BV421 Hamster IgG2, κ isotype control (Cat. No. 562612; dashed line histogram) or with the BD Horizon™ BV421 Hamster Anti-Mouse CD279 (PD-1) antibody (Cat. No. 562584/565942; solid line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD279 (PD-1) expression on resting and activated mouse splenocytes. Splenocytes from a C57BL/6 mouse were activated in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody (Cat. No. 553057) for 3 days. The resting (Left Panel) or activated (Right Panel) splenocytes were stained with either a BD Horizon™ BV421 Hamster IgG2, κ isotype control (Cat. No. 562612; dashed line histogram) or with the BD Horizon™ BV421 Hamster Anti-Mouse CD279 (PD-1) antibody (Cat. No. 562584/565942; solid line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD279 (PD-1) expression on resting and activated mouse splenocytes. Splenocytes from a C57BL/6 mouse were activated in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody (Cat. No. 553057) for 3 days. The resting (Left Panel) or activated (Right Panel) splenocytes were stained with either a BD Horizon™ BV421 Hamster IgG2, κ isotype control (Cat. No. 562612; dashed line histogram) or with the BD Horizon™ BV421 Hamster Anti-Mouse CD279 (PD-1) antibody (Cat. No. 562584/565942; solid line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD279 (PD-1) expression on resting and activated mouse splenocytes. Splenocytes from a C57BL/6 mouse were activated in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody (Cat. No. 553057) for 3 days. The resting (Left Panel) or activated (Right Panel) splenocytes were stained with either a BD Horizon™ BV421 Hamster IgG2, κ isotype control (Cat. No. 562612; dashed line histogram) or with the BD Horizon™ BV421 Hamster Anti-Mouse CD279 (PD-1) antibody (Cat. No. 562584/565942; solid line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD279 (PD-1) expression on resting and activated mouse splenocytes. Splenocytes from a C57BL/6 mouse were activated in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody (Cat. No. 553057) for 3 days. The resting (Left Panel) or activated (Right Panel) splenocytes were stained with either a BD Horizon™ BV421 Hamster IgG2, κ isotype control (Cat. No. 562612; dashed line histogram) or with the BD Horizon™ BV421 Hamster Anti-Mouse CD279 (PD-1) antibody (Cat. No. 562584/565942; solid line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD279 (PD-1) expression on resting and activated mouse splenocytes. Splenocytes from a C57BL/6 mouse were activated in culture with plate-bound Purified NA/LE Hamster Anti-Mouse CD3e antibody (Cat. No. 553057) for 3 days. The resting (Left Panel) or activated (Right Panel) splenocytes were stained with either a BD Horizon™ BV421 Hamster IgG2, κ isotype control (Cat. No. 562612; dashed line histogram) or with the BD Horizon™ BV421 Hamster Anti-Mouse CD279 (PD-1) antibody (Cat. No. 562584/565942; solid line histogram). The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable splenocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD™ CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and CompBead to ensure that BD Comp beads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime two or more BD Horizon Brilliant dyes are used in the same experiment. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
The J43 monoclonal antibody specifically recognizes CD279 which is also known as PD-1 (programmed death-1). CD279 is a 50-55-kDa glycoprotein encoded by the Pdcd1 gene of the CD28 family of the Ig superfamily. The expression of Pdcd1 mRNA and PD-1 protein is tightly regulated. PD-1 is transiently expressed on CD4-CD8 thymocytes, it is upregulated on some cell lines upon induction of apoptosis, it is induced on thymocytes and splenic T and B lymphocytes after stimulation through their antigen receptors, and it is induced on activated myeloid cells. In addition, Pdcd1 mRNA is transiently expressed in developing B lymphocytes at the pro-B-cell stage. The presence of an ITIM (Immunoreceptor Tyrosine-based Inhibitory Motif) on PD-1's intracytoplasmic region and the development of splenomegaly and breakdown of peripheral tolerance in PD-1[-/-] mice suggest that PD-1 is involved in the negative regulation of immune responses. The PD-1 ligands, B7-H1 (also known as PD-L1, CD274) and B7-DC (PD-L2, CD273), are members of the B7 family of the Ig superfamily. The J43 antibody blocks the binding of PD-1 to its two ligands.
The antibody was conjugated to BD Horizon BV421 which is part of the BD Horizon Brilliant™ Violet family of dyes. With an Ex Max near 407 nm and Em Max near 421 nm, BD Horizon BV421 can be excited by the violet laser (405 nm) and detected with a 450/50 nm filter. BD Horizon BV421 conjugates are very bright, often exhibiting a 10 fold improvement in brightness compared to Pacific BlueTM conjugates. Due to nearly identical excitation and emission properties but different spillover characteristics, BD Horizon BV421, Pacific Blue, and BD Horizon V450 cannot be used simultaneously.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.